Web NewDrugInformation.com

Neomycin Sulfate-dexamethasone Sodium Phosphate Drug - Neomycin Sulfate-dexamethasone Sodium Phosphate The trade name of the product as shown on the labeling. Dosage - SOLUTION/DROPS; OPHTHALMIC The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Dexamethasone Sodium Phosphate; Neomycin Sulfate Multiple ingredients are in alphabetical order. Strength - EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML The potency of the active ingredient(s), Dexamethasone Sodium Phosphate; Neomycin Sulfate. May repeat for multiple part products. Applicant - PHARMAFAIR The firm name holding legal responsibility for Neomycin Sulfate-dexamethasone Sodium Phosphate. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 062539 The FDA assigned number to Neomycin Sulfate-dexamethasone Sodium Phosphate. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Neomycin Sulfate-dexamethasone Sodium Phosphate. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Jan 10, 1985 The date Neomycin Sulfate-dexamethasone Sodium Phosphate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Neomycin Sulfate-dexamethasone Sodium Phosphate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Neomycin Sulfate-dexamethasone Sodium Phosphate is in. Format is RX, OTC, DISCN. Applicant Full Name - Pharmafair Inc The full name of the firm holding legal responsibility for the new application of Neomycin Sulfate-dexamethasone Sodium Phosphate. Neomycin Sulfate-dexamethasone Sodium Phosphate Decadron W/ Xylocaine Eq 4mg Phosphate/ml;10mg/ml Injectable; Injection Neodecadron Eq 0.05% Phosphate;eq 3.5mg Base/gm Ointment; Ophthalmic Neodecadron Eq 0.1% Phosphate;eq 3.5mg Base/ml Solution/drops; Ophthalmic Neomycin Sulfate And Dexamethasone Sodium Phosphate Eq 0.1% Phosphate;eq 3.5mg Base/ml Solution/drops; Ophthalmic Neomycin Sulfate-dexamethasone Sodium Phosphate Eq 0.1% Phosphate;eq 3.5mg Base/ml Solution/drops; Ophthalmic Neomycin Sulfate-dexamethasone Sodium Phosphate Eq 0.1% Phosphate;eq 3.5mg Base/ml Solution/drops; Ophthalmic Decadron Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Otic NewDrugInformation